Lung Diseases Cies Search Engine [selected websites]

Loading

Blog Archive

Jan 11, 2008

Luminex , FDA Clearance for xTAG Respiratory Viral Panel

Jan. 3, 2008 -Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its xTAG(TM) Respiratory Viral Panel (RVP). xTAG RVP is the first FDA-cleared assay to simultaneously detect and identify 12 viruses and viral subtypes that together are responsible for more than 85 percent of respiratory viral infections... Luminex' Press Release -